Related Experiment Video
Updated: Aug 14, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
High prevalence of patent foramen ovale in migraine with aura
Giovanni Ferrarini1, Giovanni Malferrari, Riccardo Zucco
1Centro Cefalee Alta Specialità, Dipartimento Area Critica, Reggio Emilia, Italy.
Abstract:
In this study we evaluated the presence of patent foramen ovale (PFO) in a cohort of 25 consecutive patients suffering from migraine with aura (MA) during an attack presenting to the emergency ward of an Italian hospital. Patients underwent brain magnetic resonance imaging (MRI) with contrast medium, routine coagulation tests, contrast transcranial echocolour-coded sonography (c-TCCS) and transoesophageal echocardiography (TEE). Of the enrolled patients, 88.7% showed a PFO according to the c-TCCS test, whereas only in 72% TEE confirmed the presence of PFO. This discordance could be due to the fact that c-TCCS is more sensitive even with shunts with minimal capacity also located in the pulmonary vasculature. After surgical treatment of the PFO, MA disappeared within two months. Also, the treatment with warfarin as well as with acetylsalicylic acid and flunarizine was able to dramatically reduce the frequency of migraine attacks. These data indicate a higher prevalence of PFO in MA vs. normal population (OR=2.92) and could suggest that the presence of arteriovenous (AV) shunts could represent a trigger for MA attacks as well as for stroke, but more studies are needed to confirm this preliminary hypothesis.
Insights
Patent foramen ovale (PFO) is highly prevalent in migraine with aura (MA) patients. Treating PFO may resolve MA attacks, suggesting a link between shunts and migraine triggers.
Area of Science:
- Neurology
- Cardiology
- Vascular Biology
Background:
- Migraine with aura (MA) is a neurological condition with complex pathophysiology.
- The potential role of cardiac shunts, specifically patent foramen ovale (PFO), in MA remains an area of investigation.
Observation:
- A cohort of 25 consecutive MA patients presenting to an emergency ward were evaluated.
- Diagnostic methods included brain MRI, coagulation tests, contrast transcranial echocolour-coded sonography (c-TCCS), and transoesophageal echocardiography (TEE).
- c-TCCS detected PFO in 88.7% of patients, while TEE confirmed it in 72%, suggesting c-TCCS may be more sensitive.
Findings:
- A significantly higher prevalence of PFO was observed in MA patients compared to the general population (Odds Ratio=2.92).
- Surgical closure of PFO led to the complete resolution of MA within two months in affected patients.
- Pharmacological treatments including warfarin, acetylsalicylic acid, and flunarizine also demonstrated a significant reduction in migraine attack frequency.
Implications:
- The findings suggest a potential causal link between PFO and MA, with arteriovenous (AV) shunts possibly acting as triggers.
- PFO may represent a modifiable risk factor for MA, warranting further investigation into screening and treatment strategies.
- These results could influence clinical practice regarding the evaluation and management of patients with migraine with aura.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Increased Intracranial Pressure ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Glaucoma: Overview

